Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report.
Get the full story...
Drug-resistant HIV at levels too low to be detected by standard tests is not unusual and may contribute to treatment failure, according to research published in PLoS Medicine.
Get the full story...
A mathematical model shows that a new wave of drug-resistant HIV is rising among among men in San Francisco who have sex with men and that this trend will continue over the next few years, according to a new study from the UCLA AIDS Institute.
Get the full story...
A new drug is giving hope to patients with HIV who have become resistant to other treatments. Researchers including a team from Australia gave patients either an older HIV drug on its own or combined with a newer medication called darunavir.
Get the full story...